Director of the Academy
Dr. Richard M. Schwartzstein is the Ellen and Melvin Gordon Professor of Medicine and Medical Education. Since joining the HMS faculty in 1986, Dr. Schwartzstein has been a member of the division of pulmonary and critical care medicine at Beth Israel Hospital and now, Beth Israel Deaconess Medical Center (BIDMC). In addition to his clinical work and research on the physiology of dyspnea, Dr. Schwartzstein has devoted a substantial portion of his career to medical education. He has been course director for Integrated Human Physiology, one of the core courses in the first year curriculum, for 15 years and has served on multiple committees with oversight of the HMS program of studies. In 2004, he was named the vice president for education at BIDMC, where he created the first hospital-based Center for Education in the Harvard system. Dr. Schwartzstein is also the executive director of the Carl J. Shapiro Institute for Education and Research at Harvard Medical School and Beth Israel Deaconess Medical Center. The Institute supports the Rabki Fellowship in Medical Education, sponsors national conferences on key educational topics biannually, provides a range of professional development activities for physicians, and oversees the Shapiro Simulation and Skills Center. Dr. Schwartzstein has a particular interest in the cognitive processes underlying analytical reasoning and the strategies for teaching and assessing critical thinking. Additionally, he has served on the MR 5 Task Force of the Association of American Medical Colleges, which developed recommendations for revisions of the Medical College Admissions Test (MCAT). In AY 12, Dr. Schwartzstein chaired a strategic planning process for HMS’ Department of Continuing Education, and in AY 13 he assumed the role of chair of the Task Force on the Redesign of the Pre- Clerkship Curriculum. In the Pathways Curriculum, Dr. Schwartzstein will serve as director of the new Homeostasis I course.
To create and nurture a diverse community of the best people committed to leadership in alleviating human suffering caused by disease